Skip to main content

Intraocular Melanoma Clinical Trials

Review the intraocular melanoma clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 26-32 of 32

Quisinostat for Preventing Metastasis after Treatment of High-Risk Uveal Melanoma
Status: Temporarily Closed to Accrual
Location: 8 locations
Tumor Infiltrating Lymphocytes and High-Dose Aldesleukin with or without Autologous Dendritic Cells in Treating Patients with Metastatic Melanoma
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Prebiotic Food-Enriched Diet to Enhance the Microbiome and Response to First-Line Immunotherapy in Patients with Stage III or IV Unresectable Cutaneous, Uveal, Acral or Mucosal Melanoma
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Status: Active
Location: 6 locations
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Status: Active
Location: 5 locations
Evaluation of the Natural History of Patients with Uveal Melanoma
Status: Active
Location: 2 locations
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio